A detailed history of Pegasus Partners Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Pegasus Partners Ltd. holds 6,721 shares of ZTS stock, worth $1.17 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,721
Holding current value
$1.17 Million
% of portfolio
0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$165.67 - $199.94 $1.11 Million - $1.34 Million
6,721 New
6,721 $1.14 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $189,189 - $244,093
-1,043 Closed
0 $0
Q4 2021

Feb 09, 2022

SELL
$193.69 - $247.03 $18,206 - $23,220
-94 Reduced 8.27%
1,043 $255,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $37,290 - $41,308
-197 Reduced 14.77%
1,137 $221,000
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $7,950 - $9,587
-51 Reduced 3.68%
1,334 $249,000
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $199,440 - $234,605
1,385 New
1,385 $218,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.